Zweig-DiMenna Associates’s Sanofi SNY Stock Holding History

Zweig-DiMenna Associates’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-215,000	Closed	-$10.6M	–	307
2015 Q1	$10.6M	Buy	+215,000	New	+$10.3M	0.45%	81

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Zweig-DiMenna Associates's SNY Position: Q2 2015 in Review

Zweig-DiMenna Associates sold out of Sanofi (SNY) in Q2 2015, closing a stake of 215,000 shares — an estimated $10.6M sold.

Zweig-DiMenna Associates first reported a position in SNY in Q1 2015 and held it in 1 quarter. The position peaked at $10.6M in Q1 2015. 503 funds tracked by Wall St. Rank hold SNY as of Q2 2015.

Zweig-DiMenna Associates reported no remaining Sanofi position as of Q2 2015 after selling out during the quarter.
Zweig-DiMenna Associates sold 215,000 Sanofi shares in Q2 2015, an estimated $10.6M.
Zweig-DiMenna Associates first reported a position in Sanofi in Q1 2015 and held it in 1 quarter.
Zweig-DiMenna Associates's Sanofi position peaked at $10.6M in Q1 2015.
503 funds tracked by Wall St. Rank held Sanofi as of Q2 2015.

Based on Zweig-DiMenna Associates's 13F filing for Q2 2015, filed 10 Aug 2015.